Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zszong@hotmail.com
    Member
    • Sep 2012
    • 17

    #1

    pacbio sequence error correction

    Hi all,

    I have some pacbio long read data, about 10x coverage of a 120M genome. I already have the reference genome. However it is not complete and there are many gaps in it. What I am trying to do is to error correct my pacbio sequence and assemble the genome. Later on I will add more illumina data trying to close the gaps.

    My question about he error correction is: Can I use the incomplete reference genome to error correct my pacbio data? My plan is to convert the genome fasta into pacBioToCA required frg format. And then feed my pacbio data and the genome frg data to the correction pipeline to output error corrected data. My concern is : will pacBioToCA accept relatively long genome scalfold data as high identity sequence to correct my pacbio data?

    Suggestions and help is greatly appreciatedl

    Stuart
  • zszong@hotmail.com
    Member
    • Sep 2012
    • 17

    #2
    I am not able to figure out how I can use the incomplete reference genome for error correction. It looks like FastaToCA converts fastq file to frg file so that it can be used as high identity sequence for error correction. However, the incomplete genome assembly in fasta file. there is no quality score files can be found. How can I get around this?

    many thanks!

    Stuart

    Comment

    • mchaisso
      Member
      • Apr 2008
      • 84

      #3
      Perhaps use the pbjelly pipeline to fill gaps? Also, with an appropriate pipeline (quiver: https://github.com/PacificBiosciences/GenomicConsensus) you may not need error correction to call accurate consensus.

      cheers,
      -mark

      Comment

      • zszong@hotmail.com
        Member
        • Sep 2012
        • 17

        #4
        Thanks for the tips! Mark. It looks like it will take me a while to figure this out. However, It sounds like interesting to me when you say I might not need to do error correction for pacbiodate since it it has 15% error rate.

        STuart

        Comment

        • jbingham
          Member
          • Jul 2011
          • 24

          #5
          Some more tips: if you want to use pacBioToCA, the approach would be to use the raw Illumina data as input to the correction step, not the draft assembly. The advantage of going back to the raw data is you may be able to correct assembly errors. The disadvantage is it takes longer to run.

          If you want to keep the assembly as is, you can install SMRT Analysis and use AHA (a hybrid assembler) to scaffold it, provided your the genome is less than about 200 MB. For larger genomes, or to really focus on the gap-filling, you can use pbjelly.

          Finally, the "no error correction" suggestion refers to the new algorithm HGAp: http://www.pacbiodevnet.com/hgap. You'll need more PacBio coverage to go that route. The benefit is you may be able to close more gaps and get a final result that's potentially as accurate as Sanger finishing.

          Comment

          • zszong@hotmail.com
            Member
            • Sep 2012
            • 17

            #6
            Thanks for your tips! jbingham. I am in the process of generating short illumina data for the error correction. I think I don't have enough coverage to try the new algorithm since my pacbio data only gives 3-4 times coverage when look into those data more carefully. The most majority of them are less than 500bp and 1000bp. Longest read is 13kb. I will post my process later.

            Thanks again to Winsettz and jbingham for helping out here!

            Stuart

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Working...